Literature DB >> 3624272

Characterization of a protein C activator from Agkistrodon contortrix contortrix venom.

W Kisiel, S Kondo, K J Smith, B A McMullen, L F Smith.   

Abstract

The protease from Southern Copperhead venom that activates protein C was purified to homogeneity by sulfopropyl (SP)-Sephadex C-50 ion-exchange chromatography, Sephadex G-150 gel filtration, and Mono-S fast protein liquid chromatography. The purified enzyme is a glycoprotein containing 16% carbohydrate, and migrated as a single band in sodium dodecyl sulfate-polyacrylamide gel electrophoresis with an apparent molecular mass of 40,000 kDa. The enzyme is composed of a single polypeptide chain possessing an NH2-terminal sequence of Val-Ile-Gly-Gly-Asp-Glu-Cys-Asn-Ile-Asn-Glu-His. The purified venom protein C activator hydrolyzed several tripeptide p-nitroanilides. The amidolytic and proteolytic activities of the enzyme were readily inhibited by phenylmethanesulfonyl fluoride, p-amidinophenylmethanesulfonyl fluoride, chloromethyl ketones, and human antithrombin III. Covalent binding of diisopropyl fluorophosphate to the enzyme was confirmed using a tritium-labeled preparation of the inhibitor. The venom protease readily activated human and bovine protein C at 1:1000 enzyme:substrate weight ratio. The protease also cleaved human prothrombin, factor X, factor IX, factor VII, and fibrinogen. Prothrombin coagulant activity decreased upon incubation with the venom protease, and the rate of this reaction was reduced in the presence of calcium. Factor X and factor IX coagulant activity increased upon incubation with the venom protease in the presence of calcium, and decreased in the absence of calcium. Human factor VII clotting activity decreased slightly upon incubation with the venom protease. Although the venom protease did not clot human fibrinogen, it nonetheless cleaved the A alpha chain of fibrinogen, and this cleavage appeared to be associated with a measurable increase in the clottability of the protease-treated fibrinogen by thrombin. These data demonstrate that the protein C activator from Southern Copperhead venom is a typical serine protease with a relatively broad specificity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624272

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  Anticoagulant proteins from snake venoms: structure, function and mechanism.

Authors:  R Manjunatha Kini
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

2.  Phylogenetic analysis of serine proteases from Russell's viper (Daboia russelli siamensis) and Agkistrodon piscivorus leucostoma venom.

Authors:  Pattadon Sukkapan; Ying Jia; Issarang Nuchprayoon; John C Pérez
Journal:  Toxicon       Date:  2011-05-27       Impact factor: 3.033

3.  Role of accelerated segment switch in exons to alter targeting (ASSET) in the molecular evolution of snake venom proteins.

Authors:  Robin Doley; Stephen P Mackessy; R Manjunatha Kini
Journal:  BMC Evol Biol       Date:  2009-06-30       Impact factor: 3.260

4.  Anti-coagulant activity of a metalloprotease: further characterization from the Indian cobra (Naja naja) venom.

Authors:  M S Kumar; V R Devaraj; B S Vishwanath; K Kemparaju
Journal:  J Thromb Thrombolysis       Date:  2010-04       Impact factor: 2.300

5.  Liver myofibroblasts activate protein C and respond to activated protein C.

Authors:  Jennifer Gillibert-Duplantier; Anne Rullier; Véronique Neaud; Walter Kisiel; Jean Rosenbaum
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

6.  Rational Design of Protein C Activators.

Authors:  Sergio Barranco-Medina; Mary Murphy; Leslie Pelc; Zhiwei Chen; Enrico Di Cera; Nicola Pozzi
Journal:  Sci Rep       Date:  2017-03-15       Impact factor: 4.379

7.  Snake Venom Extracellular vesicles (SVEVs) reveal wide molecular and functional proteome diversity.

Authors:  Victor Corassolla Carregari; Livia Rosa-Fernandes; Paulo Baldasso; Sergio Paulo Bydlowski; Sergio Marangoni; Martin R Larsen; Giuseppe Palmisano
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

Review 8.  The Urgent Need to Develop Novel Strategies for the Diagnosis and Treatment of Snakebites.

Authors:  Harry F Williams; Harry J Layfield; Thomas Vallance; Ketan Patel; Andrew B Bicknell; Steven A Trim; Sakthivel Vaiyapuri
Journal:  Toxins (Basel)       Date:  2019-06-20       Impact factor: 4.546

9.  The venom gland transcriptome of the Desert Massasauga rattlesnake (Sistrurus catenatus edwardsii): towards an understanding of venom composition among advanced snakes (Superfamily Colubroidea).

Authors:  Susanta Pahari; Stephen P Mackessy; R Manjunatha Kini
Journal:  BMC Mol Biol       Date:  2007-12-20       Impact factor: 2.946

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.